{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:25:38Z","timestamp":1789662338139,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Japan Ministry of Education","award":["24593034"],"award-info":[{"award-number":["24593034"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12885-016-2416-9","type":"journal-article","created":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T12:08:43Z","timestamp":1469621323000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Induction of artificial cancer stem cells from tongue cancer cells by defined reprogramming factors"],"prefix":"10.1186","volume":"16","author":[{"given":"Koji","family":"Harada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarannum","family":"Ferdous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Kuramitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiya","family":"Ueyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,27]]},"reference":[{"key":"2416_CR1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ctrv.2011.11.007","volume":"38","author":"G Mannelli","year":"2012","unstructured":"Mannelli G, Gallo O. Cancer stem cells hypothesis and stem cells in head and neck cancers. Cancer Treat Rev. 2012;38:515\u201339.","journal-title":"Cancer Treat Rev"},{"key":"2416_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.oraloncology.2011.10.004","volume":"48","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Filho MS, N\u00f6r JE. The biology of head and neck cancer stem cells. Oral Oncol. 2012;48:1\u20139.","journal-title":"Oral Oncol"},{"key":"2416_CR3","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1158\/1078-0432.CCR-07-4404","volume":"14","author":"SH Chiou","year":"2008","unstructured":"Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ, Tsai TH, Chou SH, Chien CS, Ku HH, Lo JF. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res. 2008;14:4085\u201395.","journal-title":"Clin Cancer Res"},{"key":"2416_CR4","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrc2499","volume":"8","author":"JE Visvader","year":"2008","unstructured":"Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer. 2008;8:755\u201368.","journal-title":"Nat Rev Cancer"},{"key":"2416_CR5","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100:3983\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2416_CR6","first-page":"5821","volume":"63","author":"SK Singh","year":"2003","unstructured":"Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003;63:5821\u20138.","journal-title":"Cancer Res"},{"key":"2416_CR7","first-page":"233","volume":"8","author":"B Ramdass","year":"2013","unstructured":"Ramdass B, Chowdhari A, Koka P. Cancer-initiating cells as target for prevention of recurring disease etiology: role of these malignant putative progenitor cells in relapse or metastasis of human cervical carcinoma. J Stem Cells. 2013;8:233\u201351. Review.","journal-title":"J Stem Cells"},{"key":"2416_CR8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc1590","volume":"5","author":"M Dean","year":"2005","unstructured":"Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer. 2005;5:275\u201384. Review.","journal-title":"Nat Rev Cancer"},{"key":"2416_CR9","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.biocel.2012.08.022","volume":"44","author":"Z Yu","year":"2012","unstructured":"Yu Z, Pestell TG, Lisanti MP, Pestell RG. Cancer stem cells. Int J Biochem Cell Biol. 2012;44:2144\u201351.","journal-title":"Int J Biochem Cell Biol"},{"key":"2416_CR10","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1158\/1078-0432.CCR-10-2639","volume":"17","author":"M Krause","year":"2011","unstructured":"Krause M, Yaromina A, Eicheler W, Koch U, Baumann M. Cancer stem cells: targets and potential biomarkers for radiotherapy. Clin Cancer Res. 2011;17:7224\u20139.","journal-title":"Clin Cancer Res"},{"key":"2416_CR11","doi-asserted-by":"crossref","first-page":"8665","DOI":"10.18632\/oncotarget.2356","volume":"5","author":"M Nishi","year":"2014","unstructured":"Nishi M, Akutsu H, Kudoh A, Kimura H, Yamamoto N, Umezawa A, Lee SW, Ryo A. Induced cancer stem-like cells as a model for biological screening and discovery of agents targeting phenotypic traits of cancer stem cell. Oncotarget. 2014;5:8665\u201380.","journal-title":"Oncotarget"},{"key":"2416_CR12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1096\/fj.12-218222","volume":"27","author":"V Tirino","year":"2013","unstructured":"Tirino V, Desiderio V, Paino F, De Rosa A, Papaccio F, La Noce M, Laino L, De Francesco F, Papaccio G. Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization. FASEB J. 2013;27:13\u201324.","journal-title":"FASEB J"},{"key":"2416_CR13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12032-014-0069-6","volume":"31","author":"M Moghbeli","year":"2014","unstructured":"Moghbeli M, Moghbeli F, Forghanifard MM, Abbaszadegan MR. Cancer stem cell detection and isolation. Med Oncol. 2014;31:69.","journal-title":"Med Oncol"},{"key":"2416_CR14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1507\/endocrj.EJ13-0526","volume":"61","author":"M Shimamura","year":"2014","unstructured":"Shimamura M, Nagayama Y, Matsuse M, Yamashita S, Mitsutake N. Analysis of multiple markers for cancer stem-like cells in human thyroid carcinoma cell lines. Endocr J. 2014;61:481\u201390.","journal-title":"Endocr J"},{"key":"2416_CR15","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1074\/mcp.M112.025460","volume":"12","author":"M Yan","year":"2013","unstructured":"Yan M, Yang X, Wang L, Clark D, Zuo H, Ye D, Chen W, Zhang P. Plasma membrane proteomics of tumor spheres identify CD166 as a novel marker for cancer stem-like cells in head and neck squamous cell carcinoma. Mol Cell Proteomics. 2013;12:3271\u201384.","journal-title":"Mol Cell Proteomics"},{"key":"2416_CR16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/039463201402700304","volume":"27","author":"M Athanassiou-Papaefthymiou","year":"2014","unstructured":"Athanassiou-Papaefthymiou M, Shkeir O, Kim D, Divi V, Matossian M, Owen JH, Czerwinski MJ, Papagerakis P, McHugh J, Bradford CR, Carey TE, Wolf GT, Prince ME, Papagerakis S. Evaluation of CD44 variant expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significance. Int J Immunopathol Pharmacol. 2014;27:337\u201349.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"2416_CR17","doi-asserted-by":"crossref","first-page":"7819","DOI":"10.1038\/srep07819","volume":"5","author":"S Shrivastava","year":"2015","unstructured":"Shrivastava S, Steele R, Sowadski M, Crawford SE, Varvares M, Ray RB. Identification of molecular signature of head and neck cancer stem-like cells. Sci Rep. 2015;5:7819.","journal-title":"Sci Rep"},{"key":"2416_CR18","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/hed.21801","volume":"34","author":"F Bhaijee","year":"2012","unstructured":"Bhaijee F, Pepper DJ, Pitman KT, Bell D. Cancer stem cells in head and neck squamous cell carcinoma: a review of current knowledge and future applications. Head Neck. 2012;34:894\u20139.","journal-title":"Head Neck"},{"key":"2416_CR19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/j.seminoncol.2012.05.011","volume":"39","author":"J Ji","year":"2012","unstructured":"Ji J, Wang XW. Clinical implications of cancer stem cell biology in hepatocellular carcinoma. Semin Oncol. 2012;39:461\u201372.","journal-title":"Semin Oncol"},{"key":"2416_CR20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/lary.21032","volume":"121","author":"MH Tabor","year":"2011","unstructured":"Tabor MH, Clay MR, Owen JH, Bradford CR, Carey TE, Wolf GT, Prince ME. Head and neck cancer stem cells: the side population. Laryngoscope. 2011;121:527\u201333.","journal-title":"Laryngoscope"},{"key":"2416_CR21","doi-asserted-by":"crossref","first-page":"517237","DOI":"10.1155\/2013\/517237","volume":"2013","author":"V Richard","year":"2013","unstructured":"Richard V, Nair MG, Santhosh Kumar TR, Pillai MR. Side population cells as prototype of chemoresistant, tumor-initiating cells. Biomed Res Int. 2013;2013:517237.","journal-title":"Biomed Res Int"},{"key":"2416_CR22","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1158\/1078-0432.CCR-09-2824","volume":"16","author":"CA O'Brien","year":"2010","unstructured":"O'Brien CA, Kreso A, Jamieson CH. Cancer stem cells and self-renewal. Clin Cancer Res. 2010;16:3113\u201320. Review.","journal-title":"Clin Cancer Res"},{"key":"2416_CR23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105\u201311.","journal-title":"Nature"},{"key":"2416_CR24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/cr.2012.13","volume":"22","author":"DG Tang","year":"2012","unstructured":"Tang DG. Understanding cancer stem cell heterogeneity and plasticity. Cell Res. 2012;22:457\u201372.","journal-title":"Cell Res"},{"key":"2416_CR25","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1373\/clinchem.2012.184655","volume":"59","author":"ND Marjanovic","year":"2013","unstructured":"Marjanovic ND, Weinberg RA, Chaffer CL. Cell plasticity and heterogeneity in cancer. Clin Chem. 2013;59:168\u201379.","journal-title":"Clin Chem"},{"key":"2416_CR26","doi-asserted-by":"publisher","unstructured":"Bao B, Ahmad A, Azmi AS, Ali S, Sarkar FH. Overview of cancer stem cells (CSCs) and mechanisms of their regulation: implications for cancer therapy. Curr Protoc Pharmacol. 2013, Chapter 14: Unit 14.25. doi: 10.1002\/0471141755.ph1425s61 .","DOI":"10.1002\/0471141755.ph1425s61"},{"key":"2416_CR27","volume":"9","author":"LL Tsai","year":"2014","unstructured":"Tsai LL, Hu FW, Lee SS, Yu CH, Yu CC, Chang YC. Oct4 mediates tumor initiating properties in oral squamous cell carcinomas through the regulation of epithelial-mesenchymal transition. PLoS One. 2014;9, e87207.","journal-title":"PLoS One"},{"key":"2416_CR28","first-page":"28","volume":"7","author":"B Qiao","year":"2013","unstructured":"Qiao B, He B, Cai J, Yang W. The expression profile of Oct4 and Sox2 in the carcinogenesis of oral mucosa. Int J Clin Exp Pathol. 2013;7:28\u201337.","journal-title":"Int J Clin Exp Pathol"},{"key":"2416_CR29","volume":"3","author":"J Wang","year":"2008","unstructured":"Wang J, Wang H, Li Z, Wu Q, Lathia JD, McLendon RE, Hjelmeland AB, Rich JN. c-Myc is required for maintenance of glioma cancer stem cells. PLoS One. 2008;3, e3769.","journal-title":"PLoS One"},{"key":"2416_CR30","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1038\/onc.2010.591","volume":"30","author":"F Yu","year":"2011","unstructured":"Yu F, Li J, Chen H, Fu J, Ray S, Huang S, Zheng H, Ai W. Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene. 2011;30:2161\u201372.","journal-title":"Oncogene"},{"key":"2416_CR31","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663\u201376.","journal-title":"Cell"},{"key":"2416_CR32","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861\u201372.","journal-title":"Cell"},{"key":"2416_CR33","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/stem.1293","volume":"31","author":"K Okita","year":"2013","unstructured":"Okita K, Yamakawa T, Matsumura Y, Sato Y, Amano N, Watanabe A, Goshima N, Yamanaka S. An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells. 2013;31:458\u201366.","journal-title":"Stem Cells"},{"key":"2416_CR34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nmeth.1591","volume":"8","author":"K Okita","year":"2011","unstructured":"Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, Hong H, Nakagawa M, Tanabe K, Tezuka K, Shibata T, Kunisada T, Takahashi M, Takahashi J, Saji H, Yamanaka S. A more efficient method to generate integration-free human iPS cells. Nat Methods. 2011;8:409\u201312.","journal-title":"Nat Methods"},{"key":"2416_CR35","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ng.127","volume":"40","author":"I Ben-Porath","year":"2008","unstructured":"Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, Weinberg, R.A. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet. 2008;40:499\u2013507.","journal-title":"Nat Genet"},{"key":"2416_CR36","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/CIRCRESAHA.111.256149","volume":"112","author":"H Okano","year":"2013","unstructured":"Okano H, Nakamura M, Yoshida K, Okada Y, Tsuji O, Nori S, Ikeda E, Yamanaka S, Miura K. Step toward safe cell therapy using induced pluripotent stem cell. Circ Res. 2013;112:523\u201333. Review.","journal-title":"Circ Res"},{"key":"2416_CR37","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2014.01.005","volume":"156","author":"K Ohnishi","year":"2014","unstructured":"Ohnishi K, Semi K, Yamamoto T, Shimizu M, Tanaka A, Mitsunaga K, Okita K, Osafune K, Arioka Y, Maeda T, Soejima H, Moriwaki H, Yamanaka S, Woltjen K, Yamada Y. Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation. Cell. 2014;156:663\u201377.","journal-title":"Cell"},{"key":"2416_CR38","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/stem.1091","volume":"30","author":"T Matsui","year":"2012","unstructured":"Matsui T, Takano M, Yoshida K, Ono S, Fujisaki C, Matsuzaki Y, Toyama Y, Nakamura M, Okano H, Akamatsu W. Neural stem cells directly differentiated from partially reprogrammed fibroblasts rapidly acquire gliogenic competency. Stem Cells. 2012;30:1109\u201319.","journal-title":"Stem Cells"},{"key":"2416_CR39","doi-asserted-by":"crossref","first-page":"7838","DOI":"10.1073\/pnas.1103113108","volume":"108","author":"J Kim","year":"2011","unstructured":"Kim J, Efe JA, Zhu S, Talantova M, Yuan X, Wang S, Lipton SA, Zhang K, Ding S. Direct reprogramming of mouse fibroblasts to neural progenitors. Proc Natl Acad Sci U S A. 2011;108:7838\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2416_CR40","first-page":"52298","volume":"95","author":"T Wang","year":"2015","unstructured":"Wang T, Choi E, Monaco MC, Major EO, Medynets M, Nath A. Direct induction of human neural stem cells from peripheral blood hematopoietic progenitor cells. J Vis Exp. 2015;95:52298.","journal-title":"J Vis Exp"},{"key":"2416_CR41","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nature09591","volume":"468","author":"E Szabo","year":"2010","unstructured":"Szabo E, Rampalli S, Risue\u00f1o RM, Schnerch A, Mitchell R, Fiebig-Comyn A, Levadoux-Martin M, Bhatia M. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature. 2010;468:521\u20136.","journal-title":"Nature"},{"key":"2416_CR42","unstructured":"Protocol for iPS cell generation using episomal vectors. Website: http:\/\/www.cira.kyoto-u.ac.jp\/j\/research\/img\/protocol\/Episomal_Protocol.pdf . Japanese, Date of access: 13th Aug 2014."},{"key":"2416_CR43","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/ab178792-f423-4aaf-8c26-950a54b8fcca","volume":"7","author":"J Muto","year":"2012","unstructured":"Muto J, Imai T, Ogawa D, Nishimoto Y, Okada Y, Mabuchi Y, Kawase T, Iwanami A, Mischel PS, Saya H, Yoshida K, Matsuzaki Y, Okano H. RNA-binding protein Musashi1 modulates glioma cell growth through the post-transcriptional regulation of Notch and PI3 kinase\/Akt signaling pathways. PLoS One. 2012;7, e33431.","journal-title":"PLoS One"},{"key":"2416_CR44","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/onc.2012.614","volume":"33","author":"M Nishi","year":"2014","unstructured":"Nishi M, Sakai Y, Akutsu H, Nagashima Y, Quinn G, Masui S, Kimura H, Perrem K, Umezawa A, Yamamoto N, Lee SW, Ryo A. Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors. Oncogene. 2014;33:643\u201352.","journal-title":"Oncogene"},{"key":"2416_CR45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1073\/pnas.0912407107","volume":"107","author":"N Miyoshi","year":"2010","unstructured":"Miyoshi N, Ishii H, Nagai K, Hoshino H, Mimori K, Tanaka F, Nagano H, Sekimoto M, Doki Y, Mori M. Defined factors induced reprogramming of gastrointestinal cancer cells. Proc Natl Acad Sci U S A. 2010;107:40\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2416_CR46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101735","volume":"9","author":"N Oshima","year":"2014","unstructured":"Oshima N, Yamada Y, Nagayama S, Kawada K, Hasegawa S, Okabe H, Sakai Y, Aoi T. Induction of cancer stem cell properties in colon cancer cells by defined factors. PLoS One. 2014;9, e101735.","journal-title":"PLoS One"},{"key":"2416_CR47","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1182\/blood-2009-07-231845","volume":"115","author":"JE Carette","year":"2010","unstructured":"Carette JE, Pruszak J, Varadarajan M, Blomen VA, Gokhale S, Camargo FD, Wernig M, Jaenisch R, Brummelkamp TR. Generation of iPSCs from cultured human malignant cells. Blood. 2010;115:4039\u201342.","journal-title":"Blood"},{"key":"2416_CR48","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1242\/jcs.054783","volume":"122","author":"J Utikal","year":"2009","unstructured":"Utikal J, Maherali N, Kulalert W, Hochedlinger K. Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J Cell Sci. 2009;122:3502\u201310.","journal-title":"J Cell Sci"},{"key":"2416_CR49","doi-asserted-by":"crossref","first-page":"8169","DOI":"10.3390\/ijms15058169","volume":"15","author":"ME Ciurea","year":"2014","unstructured":"Ciurea ME, Georgescu AM, Purcaru SO, Artene SA, Emami GH, Boldeanu MV, Tache DE, Dricu A. Cancer stem cells: biological functions and therapeutically targeting. Int J Mol Sci. 2014;15:8169\u201385.","journal-title":"Int J Mol Sci"},{"key":"2416_CR50","doi-asserted-by":"crossref","first-page":"24706","DOI":"10.3390\/ijms141224706","volume":"14","author":"A Alisi","year":"2013","unstructured":"Alisi A, Cho WC, Locatelli F, Fruci D. Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastoma. Int J Mol Sci. 2013;14:24706\u201325.","journal-title":"Int J Mol Sci"},{"key":"2416_CR51","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/stem.1195","volume":"30","author":"R Padmanabhan","year":"2012","unstructured":"Padmanabhan R, Chen KG, Gillet JP, Handley M, Mallon BS, Hamilton RS, Park K, Varma S, Mehaffey MG, Robey PG, McKay RD, Gottesman MM. Regulation and expression of the ATP-binding cassette transporter ABCG2 in human embryonic stem cells. Stem Cells. 2012;30:2175\u201387.","journal-title":"Stem Cells"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2416-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:20:23Z","timestamp":1498317623000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-016-2416-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,27]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2416"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-2416-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,27]]},"article-number":"548"}}